Endocrinopathies induites par l’immunothérapie : synthèse du consensus 2018 de la Société française d’endocrinologie

Castinetti, 2018, Introduction to expert opinion on endocrine complications of new anti-cancer therapies, Ann Endocrinol (Paris), 79, 535, 10.1016/j.ando.2018.07.001 Castinetti, 2018, French Endocrine Society Guidance on endocrine side-effects of immunotherapy, Endocr Relat Cancer Castinetti, 2018, Endocrine side-effects of new anticancer therapies: overall monitoring and conclusions, Ann Endocrinol (Paris), 79, 591, 10.1016/j.ando.2018.07.005 Illouz, 2018, Expert opinion on thyroid complications in immunotherapy, Ann Endocrinol (Paris), 79, 551, 10.1016/j.ando.2018.07.007 Cortet, 2017, Group 5: acute adrenal insufficiency in adults and pediatric patients, Ann Endocrinol (Paris), 78, 535, 10.1016/j.ando.2017.10.008 Briet, 2018, Expert opinion on pituitary complications in immunotherapy, Ann Endocrinol (Paris), 79, 562, 10.1016/j.ando.2018.07.008 Smati, 2018, Expert opinion on immunotherapy induced diabetes, Ann Endocrinol (Paris), 79, 545, 10.1016/j.ando.2018.07.006 Haissaguerre, 2018, Expert opinions on adrenal complications in immunotherapy, Ann Endocrinol (Paris), 79, 539, 10.1016/j.ando.2018.07.002